L3VLUP

AGL · ELV in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • AGL
  • ELV
010203040202120222023202420252026
Holders and value by quarter
QuarterAGLELV
Q3 2020none listed holders, n.a.30 holders, $15.0bn
Q4 2020none listed holders, n.a.29 holders, $16.7bn
Q1 2021none listed holders, n.a.25 holders, $18.6bn
Q2 20217 holders, $2.1bn30 holders, $19.4bn
Q3 20216 holders, $1.7bn26 holders, $18.5bn
Q4 20218 holders, $2.3bn29 holders, $23.3bn
Q1 20227 holders, $2.5bn31 holders, $23.9bn
Q2 20227 holders, $2.3bn32 holders, $23.3bn
Q3 20227 holders, $2.8bn34 holders, $22.6bn
Q4 20228 holders, $2.1bn34 holders, $25.5bn
Q1 20239 holders, $3.3bn39 holders, $22.5bn
Q2 20239 holders, $3.1bn38 holders, $20.6bn
Q3 202310 holders, $3.4bn34 holders, $19.8bn
Q4 202310 holders, $2.4bn36 holders, $20.3bn
Q1 20246 holders, $626m35 holders, $21.3bn
Q2 20246 holders, $716m33 holders, $22.1bn
Q3 20243 holders, $400m30 holders, $20.2bn
Q4 20241 holders, $88m32 holders, $15.9bn
Q1 20253 holders, $234m28 holders, $17.1bn
Q2 20252 holders, $106m27 holders, $14.8bn
Q3 2025none listed holders, n.a.27 holders, $12.7bn
Q4 2025none listed holders, n.a.25 holders, $17.0bn
Q1 2026none listed holders, n.a.26 holders, $13.6bn
Q2 20262 holders, $97m28 holders, $17.7bn
AGL

Agilon Health Inc

Holders
2
Reported value
$106m
Buyers
1
Sellers
1

Breadth 0 among 95 comparable managers.

ELV

Elevance Health Inc Formerly

Holders
27
Reported value
$14.8bn
Buyers
13
Sellers
16

Breadth -3 among 95 comparable managers.

Who holds both, Q2 2025

Among the 29 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →